1.1.1.29: glycerate dehydrogenase
This is an abbreviated version!
For detailed information about glycerate dehydrogenase, go to the full flat file.
Word Map on EC 1.1.1.29
-
1.1.1.29
-
glyoxylate
-
hyperoxalurias
-
photorespiration
-
photorespiratory
-
ph2
-
d-3-phosphoglycerate
-
l-glycerate
-
alanine:glyoxylate
-
medicine
- 1.1.1.29
- glyoxylate
- hyperoxalurias
-
photorespiration
-
photorespiratory
- ph2
- d-3-phosphoglycerate
- l-glycerate
-
alanine:glyoxylate
- medicine
Reaction
Synonyms
D-glycerate dehydrogenase, dehydrogenase, glycerate, GDH, glyoxalate reductase/hydroxypyruvate reductase, glyoxylate reductase, GR/HPR, GRHPR, HPR, HPR1, hydroxypyruvate dehydrogenase, hydroxypyruvate reductase, hydroxypyruvate reductase 1, NADH-dependent hydroxypyruvate reductase
ECTree
Advanced search results
Disease
Disease on EC 1.1.1.29 - glycerate dehydrogenase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
glycerate dehydrogenase deficiency
Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
glycerate dehydrogenase deficiency
Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells.
Hyperoxaluria
Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
Hyperoxaluria, Primary
Enzymological characterization of a feline analogue of primary hyperoxaluria type 2: a model for the human disease.
Hyperoxaluria, Primary
Extraction of glyceric and glycolic acids from urine with tetrahydrofuran: utility in detection of primary hyperoxaluria.
Hyperoxaluria, Primary
Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2).
Hyperoxaluria, Primary
Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2.
Hyperoxaluria, Primary
Perspectives in the assessment and management of patients with primary hyperoxaluria type I.
Infections
Enteropathogenic Escherichia coli Infection Inhibits Intestinal Ascorbic Acid Uptake via Dysregulation of Its Transporter Expression.
Metabolic Diseases
Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II.
Urolithiasis
Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
html completed